G9839 Anti-egfr mon anti therapy
G-Codes
Also known as: anti-EGFR monoclonal antibody therapy, EGFR inhibitor therapy
Healthcare quality measure documenting anti-Epidermal Growth Factor Receptor monoclonal antibody therapy administered to patient.
Clinical Context
Quality measure tracking administration of anti-EGFR monoclonal antibodies (such as cetuximab or panitumumab) in patients with EGFR-expressing tumors, particularly colorectal cancer.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.